Insiders · RCUS

RCUS insider transactions

Arcus Biosciences Inc. (RCUS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RCUS

• 96d
  Chief Executive Officer Rosen Terry J was granted 79,000 shares, increasing direct ownership by 4% to 2,236,409 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 96d
  Chief Medical Officer Markus Richard was granted 24,000 shares, increasing direct ownership by 37% to 89,647 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 96d
  General Counsel Tang Carolyn C. was granted 24,000 shares, increasing direct ownership by 19% to 148,734 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 96d
  Chief Financial Officer Goeltz Ii Robert C. was granted 24,000 shares, increasing direct ownership by 35% to 91,924 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 96d
  Chief Operating Officer Jarrett Jennifer was granted 31,000 shares, increasing direct ownership by 16% to 224,024 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 96d
  President Jaen Juan C. was granted 31,000 shares, increasing direct ownership by 9% to 377,012 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 96d
  Chief Accounting Officer Azoy Alexander was granted 21,050 shares, increasing direct ownership by 114% to 39,581 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 113d
  Chief Executive Officer Rosen Terry J gifted 35,000 shares, decreasing direct ownership by 2% to 2,157,409 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 115d
  President Jaen Juan C. sold $681,342 worth of shares (31,823 units at $21.41) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 120d
  Chief Financial Officer Goeltz Ii Robert C. sold $153,186 worth of shares (6,552 units at $23.38), decreasing direct ownership by 9% to 67,924 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 120d
  Chief Executive Officer Rosen Terry J gifted 2,400 shares, decreasing direct ownership by 0.11% to 2,192,409 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  Chief Medical Officer Markus Richard sold $210,144 worth of shares (9,546 units at $22.01), decreasing direct ownership by 13% to 65,647 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  General Counsel Tang Carolyn C. sold $318,496 worth of shares (14,468 units at $22.01), decreasing direct ownership by 10% to 124,734 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  Chief Accounting Officer Azoy Alexander sold $195,434 worth of shares (8,832 units at $22.13), decreasing direct ownership by 32% to 18,531 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  Chief Operating Officer Jarrett Jennifer sold $466,870 worth of shares (21,208 units at $22.01), decreasing direct ownership by 10% to 193,024 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  Chief Financial Officer Goeltz Ii Robert C. sold $278,739 worth of shares (12,662 units at $22.01), decreasing direct ownership by 15% to 74,476 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  President Jaen Juan C. sold $466,870 worth of shares (21,208 units at $22.01), decreasing direct ownership by 6% to 346,012 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 135d
  Chief Executive Officer Rosen Terry J sold $1,203,959 worth of shares (54,691 units at $22.01), decreasing direct ownership by 2% to 2,194,809 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 148d
  President Jaen Juan C. sold $2,050,599 worth of shares (82,997 units at $24.71) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 152d
  Chief Accounting Officer Azoy Alexander exercised 1,900 shares at a strike of $13.33 and sold $49,400 worth of shares (1,900 units at $26.00) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 157d
  Chief Financial Officer Goeltz Ii Robert C. sold $125,000 worth of shares (5,000 units at $25.00), decreasing direct ownership by 5% to 87,138 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 164d
  President Jaen Juan C. sold $1,012,764 worth of shares (50,000 units at $20.26) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 171d
  Chief Operating Officer Jarrett Jennifer exercised 50,291 shares at a strike of $1.23 and sold $954,066 worth of shares (50,291 units at $18.97) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 180d
  President Jaen Juan C. sold $87,650 worth of shares (4,314 units at $20.32) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 184d
  President Jaen Juan C. sold $2,010,578 worth of shares (96,859 units at $20.76) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 185d
  Chief Financial Officer Goeltz Ii Robert C. sold $100,000 worth of shares (5,000 units at $20.00), decreasing direct ownership by 5% to 92,138 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 206d
  Chief Operating Officer Jarrett Jennifer exercised 50,292 shares at a strike of $1.23 and sold $750,412 worth of shares (50,292 units at $14.92) (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 214d
  Chief Accounting Officer Azoy Alexander sold $36,803 worth of shares (2,831 units at $13.00), decreasing direct ownership by 9% to 27,363 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 239d
  Chief Accounting Officer Azoy Alexander sold $18,758 worth of shares (1,579 units at $11.88), decreasing direct ownership by 5% to 30,194 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Perlman Andrew J was granted 13,300 shares, increasing direct ownership by 45% to 42,625 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Falberg Kathryn E was granted 13,300 shares, increasing direct ownership by 24% to 68,600 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Machado Patrick was granted 13,300 shares, increasing direct ownership by 53% to 38,600 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Ribas Antoni was granted 13,300 shares, increasing direct ownership by 44% to 43,650 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Lacey David L. was granted 13,300 shares, increasing direct ownership by 23% to 70,952 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Kaneko Yasunori was granted 13,300 shares, increasing direct ownership by 66% to 33,300 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 324d
  Director Lambert Nicole was granted 13,300 shares, increasing direct ownership by 55% to 37,300 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 429d
  Director Kaneko Yasunori bought $201,200 worth of shares (20,000 units at $10.06), increasing direct ownership by 238% to 28,400 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 429d
  Chief Executive Officer Rosen Terry J bought $201,465 worth of shares (19,800 units at $10.18), increasing direct ownership by 0.78% to 2,554,160 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 436d
  Large owner Gilead Sciences, Inc. bought $14,999,996 worth of shares (1,363,636 units at $11.00), increasing direct ownership by 5% to 31,424,760 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 445d
  Chief Medical Officer Markus Richard was granted 75,193 shares (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 445d
  New insider Markus Richard claimed no ownership of stock in the company (SEC Form 3)

  3 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 446d
  New insider Berger Dietmar claimed no ownership of stock in the company (SEC Form 3)

  3 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  General Counsel Tang Carolyn C. was granted 37,000 shares, increasing direct ownership by 37% to 137,623 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  Chief Executive Officer Rosen Terry J was granted 165,000 shares, increasing direct ownership by 7% to 2,534,360 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  SEC Form 4 filed by Director Ribas Antoni

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  Chief Operating Officer Jarrett Jennifer was granted 50,000 shares, increasing direct ownership by 31% to 213,369 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  Chief Financial Officer Goeltz Ii Robert C. was granted 37,000 shares, increasing direct ownership by 62% to 97,138 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  Chief Accounting Officer Azoy Alexander was granted 17,100 shares, increasing direct ownership by 131% to 30,194 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  SEC Form 4 filed by Director Lacey David L.

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 460d
  President Jaen Juan C. was granted 50,000 shares, increasing direct ownership by 16% to 367,220 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 498d
  Chief Accounting Officer Azoy Alexander returned $45,616 worth of shares to the company (3,007 units at $15.17), decreasing direct ownership by 19% to 13,094 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  Chief Operating Officer Jarrett Jennifer covered exercise/tax liability with 27,501 shares, decreasing direct ownership by 14% to 163,369 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  General Counsel Tang Carolyn C. covered exercise/tax liability with 11,339 shares, decreasing direct ownership by 10% to 100,623 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  Chief Executive Officer Rosen Terry J covered exercise/tax liability with 37,882 shares, decreasing direct ownership by 2% to 2,369,360 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  Chief Medical Officer Nuyten Dimitry Sa covered exercise/tax liability with 7,856 shares, decreasing direct ownership by 8% to 87,518 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  Chief Financial Officer Goeltz Ii Robert C. covered exercise/tax liability with 10,099 shares, decreasing direct ownership by 14% to 63,732 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  Chief Accounting Officer Azoy Alexander covered exercise/tax liability with 2,969 shares, decreasing direct ownership by 16% to 16,101 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 501d
  President Jaen Juan C. covered exercise/tax liability with 17,286 shares, decreasing direct ownership by 5% to 317,220 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 514d
  Chief Accounting Officer Azoy Alexander sold $3,079 worth of shares (201 units at $15.32), decreasing direct ownership by 1% to 19,070 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
• 592d
  Chief Operating Officer Jarrett Jennifer covered exercise/tax liability with 12,670 shares, decreasing direct ownership by 6% to 190,394 units (SEC Form 4)

  4 - Arcus Biosciences, Inc. (0001724521) (Issuer)